Eyebrow Growth Pattern Analysis in Patients with Eyebrow Hypotrichosis After Receiving Topical Treatment: A Retrospective Study

September 2019 in “ Journal of cosmetic dermatology ”

Poonkiat Suchonwanit, Sasima Thammarucha

bimatoprost eyebrow hypotrichosis hair density hair diameter growth cycles Latisse

Studysummary This study found that after 24 weeks of bimatoprost 0.01% treatment, significant improvements in the density and diameter of eyebrow hair were observed, most notably in the tail section of the eyebrow.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This retrospective study analyzed the effects of a 24-week topical bimatoprost 0.01% treatment on eyebrow growth patterns in 48 patients with eyebrow hypotrichosis. The study found that the tail of the eyebrow had the lowest baseline density and diameter, with significant improvements in density and diameter observed at 4 and 16 weeks, respectively. The head and body of the eyebrow exhibited similar growth patterns. The findings confirmed that hair density, diameter, and growth cycles vary by anatomical location within the eyebrow, which could help in developing standardized treatment protocols for eyebrow hypotrichosis.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

12 / 12 results

research Minoxidil And Its Use In Hair Disorders: A Review

117 citations , August 2019 in “Drug Design Development and Therapy”

This review article provides an updated overview of the pharmacology, mechanism of action, clinical efficacy, and adverse events associated with topical minoxidil, a widely used treatment for androgenetic alopecia and other hair loss conditions, while noting that its exact mechanism is still not fully understood.

research Comparison of the Efficacy and Safety of Using 0.01% Versus 0.03% Bimatoprost for the Treatment of Eyebrow Hypotrichosis: A Randomized, Double-Blind, Split-Face, Comparative Study

4 citations , July 2019 in “Journal of cosmetic dermatology”

This clinical study reported that while both 0.01% and 0.03% bimatoprost significantly improved eyebrow density and diameter in patients with eyebrow hypotrichosis, the 0.03% concentration was more clinically preferred by patients.

research Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis

7 citations , March 2019 in “Dermatologic surgery”

In this randomized trial, bimatoprost 0.01% significantly improved eyebrow hair density and diameter in patients with eyebrow hypotrichosis compared to a placebo, with minimal adverse effects, suggesting it is an effective and safe treatment option.

research Topical Treatment of Eyebrow Hypotrichosis with Bimatoprost 0.03% Solution: Case Report and Literature Review

7 citations , May 2018 in “Curēus”

In this case report, a 60-year-old woman with eyebrow hypotrichosis experienced significant and lasting eyebrow growth after daily use of bimatoprost 0.03% solution, highlighting its potential as an effective treatment for eyebrow hair restoration.

research Therapeutic Potential of Bimatoprost for the Treatment of Eyebrow Hypotrichosis

34 citations , February 2018 in “Drug Design Development and Therapy”

This source reports that bimatoprost, a medication approved for eyelash growth, has shown efficacy in treating eyebrow hypotrichosis, suggesting it as a noninvasive, effective, and well-tolerated option for enhancing eyebrow hair.

research Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia

38 citations , March 2017 in “Expert Opinion on Investigational Drugs”

This review examines the potential of bimatoprost for treating various types of eyelash and eyebrow hypotrichosis, discussing its pharmacological properties but providing no new clinical results.

research Application of Bimatoprost Ophthalmic Solution 0.03% for the Treatment of Eyebrow Hypotrichosis: Series of Ten Cases

9 citations , January 2014 in “Dermatology online journal”

This pilot study evaluated bimatoprost ophthalmic solution 0.03% for eyebrow hair regrowth in ten female patients, but reports no new clinical results.

research Treatment of Eyebrow Hypotrichosis Using Bimatoprost: A Randomized, Double-Blind, Vehicle-Controlled Pilot Study

22 citations , April 2013 in “Dermatologic surgery”

In this study, daily application of bimatoprost 0.03% ophthalmic solution for 9 months significantly improved eyebrow appearance in individuals with mild to moderate eyebrow hypotrichosis, without observed side effects.

Efficacy and Safety of Bimatoprost 0.03% Versus Minoxidil 3% in Enhancement of Eyebrows: A Randomized, Double-Blind, Split-Face Comparative Study

research Efficacy and Safety of Bimatoprost 0.03% Versus Minoxidil 3% in Enhancement of Eyebrows: A Randomized, Double-Blind, Split-Face Comparative Study

17 citations , May 2012 in “Journal of dermatology”

This letter to the editor compares the efficacy and safety of bimatoprost 0.03% with minoxidil 3% for eyebrow enhancement but does not report any study results.

research Topical Bimatoprost for the Treatment of Eyebrow Hypotrichosis

11 citations , January 2012 in “PubMed”

This case report suggests that topical bimatoprost may promote eyebrow hair growth, as observed in a patient with eyebrow hypotrichosis, but lacks broader published scientific evidence.

research Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth

69 citations , April 2010 in “Dermatologic Surgery”

This review discusses the safety and efficacy of bimatoprost ophthalmic solution 0.03% for enhancing eyelash growth by influencing the eyelash hair cycle and follicles, and it reports no new results.

research Eyebrow Loss

29 citations , January 2007 in “American Journal of Clinical Dermatology”

This article reviews the social and functional impact of eyebrow loss and highlights the limited treatment options compared to scalp alopecia, but reports no new clinical results.